Annual Revenue
N/A
December 31, 2023
Summary
- WINT annual revenue is not available.
Performance
WINT Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Revenue
N/A
September 30, 2024
Summary
- WINT quarterly revenue is not available.
Performance
WINT Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Related metrics
TTM Revenue
N/A
September 30, 2024
Summary
- WINT TTM revenue is not available.
Performance
WINT TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
WINT Revenue Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | - | - |
| 3 y3 years | - | - | - |
| 5 y5 years | - | - | - |
WINT Revenue Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | ||||||
| 5 y | 5-year | ||||||
| alltime | all time |
Windtree Therapeutics Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2019 | $198.00 K(-88.9%) | - | - |
| Jun 2019 | - | $158.00 K(+295.0%) | $731.00 K(-55.0%) |
| Mar 2019 | - | $40.00 K(-86.8%) | $1.62 M(-9.2%) |
| Dec 2018 | $1.79 M(+20.4%) | $304.00 K(+32.8%) | $1.79 M(+12.7%) |
| Sep 2018 | - | $229.00 K(-78.2%) | $1.59 M(+15.4%) |
| Jun 2018 | - | $1.05 M(+415.2%) | $1.37 M(-6.5%) |
| Mar 2018 | - | $204.00 K(+100.0%) | $1.47 M(-1.0%) |
| Dec 2017 | $1.49 M(-27.3%) | $102.00 K(+500.0%) | $1.49 M(-35.0%) |
| Sep 2017 | - | $17.00 K(-98.5%) | $2.28 M(-29.3%) |
| Jun 2017 | - | $1.15 M(+423.7%) | $3.23 M(+47.6%) |
| Mar 2017 | - | $219.00 K(-75.7%) | $2.19 M(+7.1%) |
| Dec 2016 | $2.04 M(+106.9%) | $900.00 K(-6.3%) | $2.04 M(+13.6%) |
| Sep 2016 | - | $961.00 K(+806.6%) | $1.80 M(+99.2%) |
| Jun 2016 | - | $106.00 K(+41.3%) | $902.00 K(+3.6%) |
| Mar 2016 | - | $75.00 K(-88.5%) | $871.00 K(-11.8%) |
| Dec 2015 | $987.00 K(-65.2%) | $655.00 K(+892.4%) | $987.00 K(-34.9%) |
| Sep 2015 | - | $66.00 K(-12.0%) | $1.52 M(-23.3%) |
| Jun 2015 | - | $75.00 K(-60.7%) | $1.98 M(-34.0%) |
| Mar 2015 | - | $191.00 K(-83.9%) | $3.00 M(+5.6%) |
| Dec 2014 | $2.83 M(+630.7%) | $1.18 M(+124.7%) | $2.83 M(+64.4%) |
| Sep 2014 | - | $527.00 K(-51.8%) | $1.72 M(+37.2%) |
| Jun 2014 | - | $1.09 M(+3425.8%) | $1.26 M(+263.3%) |
| Mar 2014 | - | $31.00 K(-57.5%) | $346.00 K(-10.6%) |
| Dec 2013 | $388.00 K(+99.0%) | $73.00 K(+21.7%) | $387.00 K(-24.0%) |
| Sep 2013 | - | $60.00 K(-67.0%) | $509.00 K(+13.4%) |
| Jun 2013 | - | $182.00 K(+152.8%) | $449.00 K(+68.2%) |
| Mar 2013 | - | $72.00 K(-63.1%) | $267.00 K(+36.9%) |
| Dec 2012 | $195.00 K(-66.5%) | $195.00 K(-3.0%) | $195.00 K(-66.5%) |
| Dec 2011 | $582.00 K(-87.3%) | - | - |
| Jun 2011 | - | $201.00 K(-47.2%) | $582.00 K(+52.8%) |
| Mar 2011 | - | $381.00 K(+662.0%) | $381.00 K(-91.7%) |
| Dec 2008 | $4.60 M(+3332.8%) | - | - |
| Sep 2008 | - | $50.00 K(-98.0%) | $4.60 M(+1.1%) |
| Jun 2008 | - | $2.50 M(+22.0%) | $4.55 M(+122.0%) |
| Mar 2008 | - | $2.05 M(+6969.0%) | $2.05 M(+1429.9%) |
| Dec 2005 | $134.00 K(-88.9%) | $29.00 K(+45.0%) | $134.00 K(-43.9%) |
| Sep 2005 | - | $20.00 K(-16.7%) | $239.00 K(-47.5%) |
| Jun 2005 | - | $24.00 K(-60.7%) | $455.00 K(-59.7%) |
| Mar 2005 | - | $61.00 K(-54.5%) | $1.13 M(-6.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2004 | $1.21 M(+16.6%) | $134.00 K(-43.2%) | $1.21 M(-3.8%) |
| Sep 2004 | - | $236.00 K(-66.1%) | $1.26 M(+3.1%) |
| Jun 2004 | - | $697.00 K(+390.8%) | $1.22 M(+55.3%) |
| Mar 2004 | - | $142.00 K(-22.0%) | $785.00 K(-24.2%) |
| Dec 2003 | $1.04 M(-41.8%) | $182.00 K(-8.1%) | $1.04 M(-17.0%) |
| Sep 2003 | - | $198.00 K(-24.7%) | $1.25 M(-12.0%) |
| Jun 2003 | - | $263.00 K(-33.1%) | $1.42 M(-26.8%) |
| Mar 2003 | - | $393.00 K(-0.3%) | $1.94 M(+8.8%) |
| Dec 2002 | $1.78 M(+60.3%) | $394.00 K(+7.1%) | $1.78 M(+12.4%) |
| Sep 2002 | - | $368.00 K(-53.0%) | $1.58 M(+12.1%) |
| Jun 2002 | - | $783.00 K(+230.4%) | $1.41 M(+58.3%) |
| Mar 2002 | - | $237.00 K(+20.3%) | $893.00 K(-19.7%) |
| Dec 2001 | $1.11 M(+50.1%) | $197.00 K(0.0%) | $1.11 M(+1.2%) |
| Sep 2001 | - | $197.00 K(-24.8%) | $1.10 M(-23.7%) |
| Jun 2001 | - | $262.00 K(-42.5%) | $1.44 M(-2.3%) |
| Mar 2001 | - | $456.00 K(+147.8%) | $1.47 M(+39.2%) |
| Dec 2000 | $741.00 K(+316.3%) | $184.00 K(-65.8%) | $1.06 M(+24.2%) |
| Sep 2000 | - | $538.00 K(+81.8%) | $853.00 K(+105.5%) |
| Jun 2000 | - | $296.00 K(+622.0%) | $415.00 K(+245.8%) |
| Mar 2000 | - | $41.00 K(-286.4%) | $120.00 K(+3.4%) |
| Dec 1999 | $178.00 K(+78.0%) | -$22.00 K(-122.0%) | $116.00 K(-171.6%) |
| Sep 1999 | - | $100.00 K(+9900.0%) | -$162.00 K(0.0%) |
| Jun 1999 | - | $1000.00(-97.3%) | -$162.00 K(+157.1%) |
| Mar 1999 | - | $37.00 K(-112.3%) | -$63.00 K(<-9900.0%) |
| Dec 1998 | $100.00 K(+9900.0%) | -$300.00 K(-400.0%) | $0.00(-100.0%) |
| Sep 1998 | - | $100.00 K(0.0%) | $201.00 K(0.0%) |
| Jun 1998 | - | $100.00 K(0.0%) | $201.00 K(0.0%) |
| Mar 1998 | - | $100.00 K(-201.0%) | $201.00 K(0.0%) |
| Dec 1997 | $1000.00(-99.0%) | -$99.00 K(-199.0%) | $201.00 K(-33.0%) |
| Sep 1997 | - | $100.00 K(0.0%) | $300.00 K(0.0%) |
| Jun 1997 | - | $100.00 K(0.0%) | $300.00 K(0.0%) |
| Mar 1997 | - | $100.00 K(0.0%) | $300.00 K(0.0%) |
| Dec 1996 | $100.00 K(0.0%) | - | - |
| Sep 1996 | - | $100.00 K(0.0%) | $300.00 K(0.0%) |
| Jun 1996 | - | $100.00 K(0.0%) | $300.00 K(0.0%) |
| Mar 1996 | - | $100.00 K(0.0%) | $300.00 K(0.0%) |
| Dec 1995 | $100.00 K | - | - |
| Sep 1995 | - | $100.00 K(0.0%) | $300.00 K(+50.0%) |
| Jun 1995 | - | $100.00 K(0.0%) | $200.00 K(+100.0%) |
| Mar 1995 | - | $100.00 K | $100.00 K |
FAQ
- What is the all time high annual revenue for Windtree Therapeutics?
- What is the all time high quarterly revenue for Windtree Therapeutics?
- What is the all time high TTM revenue for Windtree Therapeutics?
What is the all time high annual revenue for Windtree Therapeutics?
Windtree Therapeutics all-time high annual revenue is $4.60 M
What is the all time high quarterly revenue for Windtree Therapeutics?
Windtree Therapeutics all-time high quarterly revenue is $2.50 M
What is the all time high TTM revenue for Windtree Therapeutics?
Windtree Therapeutics all-time high TTM revenue is $4.60 M